Laboratory Innovation Towards Quality Program Sustainability
| Autor: | Ralph Timperi, Alash'le Abimiku, William A. Blattner |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Counseling
Economic growth Quality management Quality Assurance Health Care media_common.quotation_subject 030231 tropical medicine HIV Infections Context (language use) Sensitivity and Specificity Specimen Handling 03 medical and health sciences 0302 clinical medicine Acquired immunodeficiency syndrome (AIDS) Virology Humans Medicine Quality (business) 030212 general & internal medicine Developing Countries Accreditation media_common Blood Specimen Collection Rapid diagnostic test business.industry AIDS Serodiagnosis medicine.disease CD4 Lymphocyte Count Infectious Diseases Quality management system Molecular Diagnostic Techniques Practice Guidelines as Topic business Quality assurance Program Evaluation |
| Zdroj: | Current HIV/AIDS Reports. 13:202-208 |
| ISSN: | 1548-3576 1548-3568 |
| Popis: | Laboratory innovation significantly affects program sustainability of HIV programs in low and middle income countries (LMICs) far beyond its immediate sphere of impact. Innovation in rapid development of diagnostic technologies, improved quality management systems, strengthened laboratory management, affordable external quality assurance and accreditation schemes, and building local capacity have reduced costs, brought quality improvement to point-of-care testing, increased access to testing services, reduced treatment and prevention costs and opened the door to the real possibility of ending the AIDS epidemic. However, for effectively implemented laboratory innovation to contribute to HIV quality program sustainability, it must be implemented within the overall context of the national strategic plan and HIV treatment programs. The high quality of HIV rapid diagnostic test was a breakthrough that made it possible for more persons to learn their HIV status, receive counseling, and if infected to receive treatment. Likewise, the use of dried blood spots made the shipment of samples easier for the assessment of different variables of HIV infection-molecular diagnosis, CD4+ cell counts, HIV antibodies, drug resistance surveillance, and even antiretroviral drug level measurements. Such advancement is critical for to reaching the UNAIDS target of 90-90-90 and for bringing the AIDS epidemic to an end, especially in LMICs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink